
Paclitaxel
Microtubule-stabilizing taxane chemotherapy agent for various solid tumors.
Indications:
Expanding Injectable Portfolio
Next-generation oncology injectables including taxanes, antimetabolites, and targeted monoclonal antibodies for comprehensive cancer care.
Explore our portfolio of 6 high-quality oncology products designed to meet the highest international standards.

Microtubule-stabilizing taxane chemotherapy agent for various solid tumors.
Indications:

Second-generation taxane with broader cancer treatment applications.
Indications:

Vinca alkaloid chemotherapy agent for hematological malignancies.
Indications:

Nucleoside analog antimetabolite for solid tumor chemotherapy.
Indications:

Antifolate chemotherapy agent for lung cancer and mesothelioma treatment.
Indications:

Proteasome inhibitor for blood cancer treatment.
Indications:
Our commitment to quality is backed by international certifications and regulatory compliance across multiple markets.
Available
Products manufactured at WHO Good Manufacturing Practice certified facilities
36AARCP2455C1Z8
Registered for Goods and Services Tax in India
UDYAM-TS-02-0354028
Micro, Small and Medium Enterprises registration
Just say available
Central and state drug regulatory approvals in India
International regulatory submissions for major markets
Interested in our oncology products? Contact us for product catalogs, regulatory documentation, or partnership opportunities.
Oncology product development and registration
Technology transfer and formulation development
Contract manufacturing partnerships with WHO-GMP facilities
Regulatory dossier support for FDA, EMA, TGA, COFEPRIS and Asian markets
Licensing and distribution partnerships globally
Contact our team for detailed product specifications, regulatory documentation, or partnership opportunities.